Autobio Diagnostics Co., Ltd.
603658
Clasificación en acciones
#4904
Autobio Diagnostics Co., Ltd. specializes in the full lifecycle of clinical... Autobio Diagnostics Co., Ltd. specializes in the full lifecycle of clinical diagnostic products, from their initial research and development to manufacturing and market distribution. Their diverse offerings encompass a range of reagents for immunoassay, biochemistry, microbiology, and in-vitro diagnostics (IVD). Additionally, they provide advanced automated and semi-automated instrumentation, alongside comprehensive medical laboratory solutions. Notable immunoassay products include the AutoLumo A2000 Plus automatic chemiluminescence immunoassay analyzer, automated microplate chemiluminescent enzyme immunoassays, LUmo luminometers, PHOmo microplate readers, and iWO microplate washers. Within their microbiology division, they offer automated blood culture systems, blood culture bottles, AUTOMIC strips, and mycoplasma IES. Founded in 1998, the company originally operated as Lifeclone Diagnostics Co., Ltd. before adopting its current name, Autobio Diagnostics Co., Ltd., in 2003. Headquartered in Zhengzhou, China, it functions as a subsidiary of Zhengzhou Auto Industrial Co., Ltd.
Precio por acción
$5.15
Última sincronización: 2026-10-22
Capitalización bursátil
$2.94B
Cambio (1 día)
0.97%
Cambio (1 año)
-5.80%
País
CN
Comercio Autobio Diagnostics Co., Ltd. (603658)
Categoría
Healthcare
Ingresos de Autobio Diagnostics Co., Ltd. (603658)
Ingresos en Jun 2026 TTM: $632.52M
Según los últimos informes financieros de Autobio Diagnostics Co., Ltd., los ingresos actuales de la empresa (TTM) son $632.52M. En 2024, la empresa obtuvo unos ingresos de $612.57M una disminución en comparación con los ingresos del año 2023, que fueron de $627.76M. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Autobio Diagnostics Co., Ltd. desde 2011 hasta 2026
Ingresos al final de cada año
| Año | Ingresos | Cambiar |
|---|---|---|
| 2026 (TTM) | $632.52M | 4.71% |
| 2025 | $604.08M | -1.39% |
| 2024 | $612.57M | -2.42% |
| 2023 | $627.76M | -2.51% |
| 2022 | $643.91M | 8.68% |
| 2021 | $592.51M | 29.97% |
| 2020 | $455.88M | 18.47% |
| 2019 | $384.79M | 37.17% |
| 2018 | $280.53M | 30.36% |
| 2017 | $215.20M | 52.43% |
| 2016 | $141.18M | 27.96% |
| 2015 | $110.33M | 21.32% |
| 2014 | $90.94M | 34.75% |
| 2013 | $67.49M | 32.28% |
| 2012 | $51.02M | 51.82% |
| 2011 | $33.60M | 0.00% |
Ingresos de empresas similares o competidoras
| Empresa | Ingresos | Diferencia de ingresos | País |
|---|---|---|---|
| $47.35B | 7,386.03% |
US
|
|
| $25.61B | 3,948.54% |
US
|
|
| $2.71B | 327.98% |
US
|
|
| $8.02B | 1,167.55% |
CN
|
|
| $7.37B | 1,065.49% |
US
|
